Patents by Inventor Johan Evenäs

Johan Evenäs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS
    Publication number: 20210101913
    Abstract: A compound of formula (I?) wherein R6 is H, C1-6alkyl, —(CH2)pCOOH, —(CH2)pCOOC1-6alkyl, —(CH2)pCONH2, —(CH2)pCONHC1-6alkyl, —(CH2)pCON(C1-6alkyl)2, R7 is as defined for R6; or and R7 taken together with the atoms joining them can form a 6-membered aromatic or non aromatic, saturated or unsaturated, carbocyclic or heteroatom containing (e.g.
    Type: Application
    Filed: October 21, 2020
    Publication date: April 8, 2021
    Inventors: Berit Johansen, Marcel Sandberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs, Thomas Brimert, Kildahl-Andersen Geir
  • 2-oxothiatole compounds having activity as cPLAinhibitors for the treatment of inflammatory disorders and hyperproliferative disorders
    Patent number: 10851114
    Abstract: A compound of formula (I?) wherein R6 is H, C1-6alkyl, —(CH2)pCOOH, —(CH2)pCOOC1-6alkyl, —(CH2)pCONH2, —(CH2)pCONHC1-6alkyl, —(CH2)pCON(C1-6alkyl)2, R7 is as defined for R6; or and R7 taken together with the atoms joining them can form a 6-membered aromatic or non aromatic, saturated or unsaturated, carbocyclic or heteroatom containing (e.g.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: December 1, 2020
    Assignee: Avexxin AS
    Inventors: Berit Johansen, Marcel Sandberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs, Thomas Brimert, Kildahl-Andersen Geir
  • Compounds for modulating aquaporins
    Patent number: 10730865
    Abstract: The invention relates to compounds of formula (I) pharmaceutical compositions thereof and methods for modulating aquaporin 9.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: August 4, 2020
    Assignee: APOGLYX AB
    Inventors: Johan Evenas, Joakim Larsson, Klaus Dreisch
  • 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS
    Publication number: 20190345168
    Abstract: A compound of formula (I?) wherein R6 is H, C1-6alkyl, —(CH2)pCOOH, —(CH2)pCOOC1-6alkyl, —(CH2)pCONH2, —(CH2)pCONHC1-6alkyl, —(CH2)pCON(C1-6alkyl)2, R7 is us defined for R6; or and R7 taken together with the atoms joining them can form a 6-membered aromatic or non aromatic, saturated or unsaturated, carbocyclic or heteroatom containing (e.g.
    Type: Application
    Filed: December 10, 2018
    Publication date: November 14, 2019
    Inventors: Berit Johansen, Marcel Sandberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs, Thomas Brimert, Kildahl-Andersen Geir
  • 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders
    Patent number: 10150781
    Abstract: A compound of formula (I?) wherein R6 is H, C1-6alkyl, —(CH2)pCOOH, —(CH2)pCOOC1-6alkyl, —(CH2)pCONH2, —(CH2)pCONHC1-6alkyl, —(CH2)pCON(C1-6alkyl)2, R7 is as defined for R6; or R6 and R7 taken together with the atoms joining them can form a 6-membered aromatic or non aromatic, saturated or unsaturated, carbocyclic or heteroatom containing (e.g.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: December 11, 2018
    Assignee: Avexxin AS
    Inventors: Berit Johansen, Marcel Sanderberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs, Thomas Brimert, Kildahl-Andersen Geir
  • Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes
    Patent number: 10011597
    Abstract: Disclosed are compounds, pharmaceutical compositions and methods for modulating aquaporin 9.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: July 3, 2018
    Assignee: APOGLYX AB
    Inventors: Michael Rützler, Thomas Brimert, Klaus Dreisch, Johan Evenäs, Joakim Larsson
  • 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS
    Publication number: 20170166589
    Abstract: A compound of formula (I?) wherein R6 is H, C1-6alkyl, —(CH2)pCOOH, —(CH2)pCOOC1-6alkyl, —(CH2)pCONH2, —(CH2)pCONHC1-6alkyl, —(CH2)pCON(C1-6alkyl)2, R7 is as defined for R6; or R6 and R7 taken together with the atoms joining them can form a 6-membered aromatic or non aromatic, saturated or unsaturated, carbocyclic or heteroatom containing (e.g.
    Type: Application
    Filed: August 3, 2015
    Publication date: June 15, 2017
    Inventors: Berit Johansen, Marcel Sanderberg, Inger-Reidun Aukrust, George Kokotos, Johan Evenäs, Thomas Brimert, Kildahl-Andersen Geir